Brand Engagement Network (BNAI) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
30 Jun, 2026Executive summary
Achieved significant progress in market validation, expanding from 2 to 6 proof-of-concept (POC) projects in Q2, with expectations for continued growth in the second half of the year.
Advanced several POCs and pilot programs, particularly in healthcare and automotive, with early signs of commercial readiness in healthcare and education.
Introduced Skye, an AI assistant, and achieved HIPAA compliance and SOC 2 Type 1 certification, enhancing platform maturity and credibility in healthcare.
Closed private placements in May and July 2024, raising approximately $5.3 million and improving liquidity.
Promoted Paul Chang to Co-CEO, focusing on commercial operations and growth.
Financial highlights
Revenue for Q2 2024 was $49,790, unchanged from Q2 2023, with minimal book revenue reflecting early-stage commercialization.
Net loss for Q2 2024 was $(3.05) million, compared to $(3.11) million in Q2 2023; net loss for the six months ended June 30, 2024 was $(9.93) million, up from $(5.75) million in 2023.
Operating expenses rose to $13.2 million for the six months ended June 30, 2024, up from $5.7 million year-over-year, driven by higher G&A, R&D, and transaction costs.
Cash and cash equivalents at June 30, 2024 were $1.43 million, down from $1.69 million at December 31, 2023.
Recognized a $1.8 million gain on extinguishment of combination-related liabilities through negotiated settlement of accounts payable.
Outlook and guidance
Anticipates conversion of POCs and pilots into recurring revenue and production-ready deployments in the second half of 2024, with further acceleration expected in 2025.
Management expects continued operating losses and negative cash flows for at least the next 12 months, requiring substantial additional capital.
Plans to invest more in commercial and sales teams as product commercialization ramps up.
Latest events from Brand Engagement Network
- Net loss narrowed and liabilities reduced, but liquidity and funding risks persist.BNAI
Q1 202615 May 2026 - Net loss narrowed to $8.6M on minimal revenue; going concern risks and capital needs persist.BNAI
Q4 202516 Apr 2026 - Safe, customizable AI platform secures funding and partnerships, targeting healthcare deployments.BNAI
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026 - Q3 2024 featured revenue growth, a $5.8M net loss, and a $19.5M Cataneo acquisition plan.BNAI
Q3 202414 Jan 2026 - Double-digit growth in key metrics and strong liquidity set the stage for 2026 expansion.BNAI
Q3 202530 Dec 2025 - $13.475M write-off, $19.5M Cataneo deal, and new sector partnerships drive global AI growth.BNAI
Q4 202426 Dec 2025 - Q2 2025 saw first revenue, major cost cuts, and net income, but liquidity risks remain.BNAI
Q2 202516 Dec 2025 - Key votes include director elections, auditor ratification, and a reverse stock split for NASDAQ compliance.BNAI
Proxy Filing2 Dec 2025 - Pre-revenue AI firm registers 8.1M shares for resale, highlighting urgent capital needs and dilution risk.BNAI
Registration Filing29 Nov 2025